Related Articles
Clinical predictors of pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
Characterization of triple negative breast cancer gene expression profiles in Mexican patients
Strong impact of pathological node‑negative on long‑term overall survival of patients with triple‑negative breast cancer receiving neoadjuvant chemotherapy
Downregulation of BCSG1 may correlate with better outcome of neoadjuvant chemotherapy for triple-negative breast cancer
Phosphorylated mTOR is associated to androgen receptor expression in early triple-negative breast cancer